NCT07837427

Brief Summary

This study is being done to find out if the height of the fluid bag and the direction of the surgical cut affect the pressure of the fluid used during unilateral biportal endoscopic (UBE) spine surgery. UBE is a minimally invasive surgery for the spine. During this surgery, fluid is used to keep the surgical area clear and to control bleeding. The pressure of this fluid may affect how clear the surgical view is, how much bleeding occurs, and how well patients recover after surgery. We will also collect disc tissue removed during surgery to study how disc degeneration is related to factors such as sex, age, mechanical stress, and injury. About 80 patients aged 18 to 75 who are scheduled for UBE surgery at our hospital will take part. Patients will be randomly assigned to one of four groups based on two things: the height of the fluid bag (0.9 meters or 1.0 meters) and the direction of the surgical cut (horizontal or vertical). We will measure the fluid pressure around the spinal covering during surgery and record how clear the surgical view is. After surgery, we will track patients' pain and recovery for at least 6 months. This study has been approved by the hospital ethics committee.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Feb 2026Jan 2028

Study Start

First participant enrolled

February 5, 2026

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 23, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

1.8 years

First QC Date

September 18, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

Unilateral Biportal EndoscopyUBEIrrigation PressureFluid Bag HeightIncision DirectionSurgical Field ClarityPostoperative Recovery

Outcome Measures

Primary Outcomes (1)

  • Irrigation pressure around the dura

    Intraoperative irrigation pressure around the dura measured continuously during UBE surgery.

    During surgery

Study Arms (4)

0.9 m Fluid Bag Height + Transverse Incision

EXPERIMENTAL

UBE surgery with 0.9 m fluid bag height and transverse incision.

Procedure: Unilateral Biportal Endoscopic Surgery

0.9 m Fluid Bag Height + Longitudinal Incision

EXPERIMENTAL

UBE surgery with 0.9 m fluid bag height and longitudinal incision.

Procedure: Unilateral Biportal Endoscopic Surgery

1.0 m Fluid Bag Height + Transverse Incision

EXPERIMENTAL

UBE surgery with 1.0 m fluid bag height and transverse incision.

Procedure: Unilateral Biportal Endoscopic Surgery

1.0 m Fluid Bag Height + Longitudinal Incision

EXPERIMENTAL

UBE surgery with 1.0 m fluid bag height and longitudinal incision.

Procedure: Unilateral Biportal Endoscopic Surgery

Interventions

UBE surgery performed with specified fluid bag height (0.9 m or 1.0 m) and incision direction (transverse or longitudinal).

0.9 m Fluid Bag Height + Longitudinal Incision0.9 m Fluid Bag Height + Transverse Incision1.0 m Fluid Bag Height + Longitudinal Incision1.0 m Fluid Bag Height + Transverse Incision

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>= 18 years and \< 75 years.
  • Patients scheduled for unilateral biportal endoscopic (UBE) surgery for lumbar degenerative disease at the First Affiliated Hospital of Kunming Medical University between February 2026 and December 2027.
  • Follow-up duration \> 6 months.
  • Complete clinical and follow-up data available.
  • Voluntary participation and signed informed consent.

You may not qualify if:

  • History of tuberculosis, infection, tumor, or trauma.
  • Severe cardiac, hepatic, or renal insufficiency.
  • History of chronic lung disease, liver disease, HIV infection, diabetes, or renal insufficiency.
  • Psychiatric disorders or inability to comply with follow-up.
  • Severe osteoporosis.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, 650032, China

RECRUITING

MeSH Terms

Conditions

Intervertebral Disc DisplacementSpinal Stenosis

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into four parallel groups based on two factors: fluid bag height (0.9 m or 1.0 m) and incision direction (horizontal or vertical). Randomization will be performed using computer-generated random numbers and sealed opaque envelopes.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
The First Affiliated Hospital of Kunming Medical University

Study Record Dates

First Submitted

September 18, 2026

First Posted

September 23, 2026

Study Start

February 5, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study involves a small sample of patients from a single center, and the data contain sensitive personal and surgical information. Protecting participant privacy and complying with local ethics regulations are the primary reasons for not sharing the data.

Locations